Skip to main content

Table 3 Lipid profile: concentrations and ratios, by particle size phenotype and MS status (N = 185)

From: Observational study of lipid profile and LDL particle size in patients with metabolic syndrome

 

Phenotype A (> 260 Å)

(N = 127)

Phenotype B (≤ 260 Å)

(N = 58)

p-value3

 

No MS

MS

p -value1

No MS

MS

p -value2

 

Plasma cholesterol (mg/dL)

188 ± 35.9

196.1 ± 83.6

0.279

245 ± 56

227 ± 48

0.721

0.001*

Plasma triglycerides (mg/dL)

101 [70-129.3]

129 [91-195]

> 0.001*

282 [265-298]

245 [178-296]

0.529

> 0.001*

LDL cholesterol (mg/dL)

106.4 ± 31.8

112 ± 34

0.413

137 ± 54

124 ± 32

1.000

0.064

HDL cholesterol (mg/dL)

60 [52-69]

53 [41-63]

0.001*

52 [47-56]

42 [38-52]

0.441

0.004*

Apo A-I (mg/dL)

160.6 ± 22.1

159.37 ± 31.7

0.632

168 ± 4.24

158.7 ± 26.5

0.400

0.328

Apo A-II (mg/dL)

31 [28-33]

32 [27-38]

0.212

36.5 [35-38]

34 [30-41]

0.857

0.337

Apo B (mg/dL)

95.4 ± 23.1

105.1 ± 21.4

0.031*

139 ± 24.1

122.5 ± 31.2

0.400

0.001*

Lipoprotein (a) (mg/dL)

18.6 [4.9-43]

14.3 [4.2-33.7]

0.405

1.25 [1.2-1.3]

19.5 [12.9-47.3]

0.012*

0.353

Apo B/Apo A-I ratio

0.60 ± 0.16

0.69 ± 0.19

0.024*

0.83 ± 0.12

0.78 ± 0.18

0.610

0.001*

Plasma cholesterol/HDL-c ratio

3.22 ± 0.84

3.84 ± 1.18

0.001*

4.72 ± 0.50

4.82 ± 1.17

0.889

> 0.001*

Plasma triglycerides/HDL-c ratio

1.65 [1.13-2.45]

2.49 [1.53-3.67]

> 0.001*

5.55 [4.73-6.34]

5.49 [3.99-6.85]

0.963

> 0.001*

Log (TG/HDL-c) ratio

0.20 ± 0.24

0.38 ± 0.29

> 0.001*

0.74 ± 0.08

0.72 ± 0.19

0.963

> 0.001*

LDL particle size (Å)

273.6 [271.1-274.7]

271.2 [267.7-273.7]

> 0.001*

255.25 [255-255.5]

259 [257.6-260]

0.114

> 0.001*

  1. Notes: Data are mean ± SD, and median and interquartile range. * Statistically significant differences.
  2. p-value1: significance between MS and non-MS in phenotype A patients.
  3. p-value2: significance between MS and non-MS in phenotype B patients.
  4. p-value3: significance between phenotypes.